Among 63,000 enumerated population aged ≥50 years in 21 districts, 56771 (90.1%) were assessed for diabetes. The prevalence of diabetes was 11.8%. The prevalence of KD was 8.0% whereas ND was 3.8%. Males showed a similar prevalence of diabetes (12%) as females (11.7%). Known diabetics comprised 67.3% participants, while 32.7% were new diabetics. Highest prevalence of diabetes was observed in 70-79 years age group at 13.2%. Nearly 40% of KDs were diagnosed 1-4 years back while 5.3% of KDs reported diagnosis within past one-year.
Presenting visual acuity < 3/60 in better eye
Presenting visual acuity < 6/60 – 3/60 in better eye
Presenting visual acuity < 6/18 – 6/60 in better eye
Presenting visual acuity < 6/12 – 6/18 in better eye
Presenting visual acuity <6/18-3/60 in better eye
Presenting visual acuity < 6/18 in better eye
A person with impairment of visual functioning even after treatment and/or standard refractive correction, and a visual acuity of less than 6/18 to light perception, or a visual field of less than 10 degree from the point of fixation.
Cataract Surgical Coverage (Person) indicates how many persons received cataract surgery (one or both eyes) among all who were bilaterally pinhole blind due to cataract.
The numerator includes persons with one operated and one pinhole blind eye and persons with bilateral (pseudo) aphakia. The denominator includes the numerator, plus persons bilaterally pinhole blind due to cataract. Besides this, the indicator can also be calculated separately for PinVA <6/60 and <6/18.
Cataract Surgical Coverage (Eye) measures the proportions of eyes pinhole blind due to cataract, which have been operated so far.
The numerator includes all (pseudo) aphakic eyes. The denominator includes the numerator, plus eyes pinhole blind due to cataract. Besides this, the indicator can also be calculated separately for PinVA <6/60 and <6/18.
| Diabetics | Male | Female | Total |
|---|---|---|---|
| Known diabetes | 8.2% | 7.8% | 8.0% |
| Newly diagnosed diabetes | 3.8% | 3.9% | 3.8% |
| Total | 12.0% | 11.7% | 11.8% |
| Diabetic population aged ≥50 years (Scottish classification) | Complete DR evaluation (N=5986) | Total Examine (N=56771) |
|---|---|---|
| Retinopathy | ||
| No visible retinopathy (R0) | 4976(83.1) | 55761 (98.2) |
| Mild (R1) | 705 (11.8) | 705 (1.2) |
| Observable background (R2) | 155 (2.6) | 155 (0.3) |
| Referable (R3) | 113 (1.9) | 113 (0.2) |
| Proliferative (R4) | 37 (0.6) | 37 (0.1) |
| Any retinopathy | 1010 (16.9) | 1010 (1.8) |
| Maculopathy | ||
| No maculopathy (M0) | 5569 (93.0) | 56354 (99.3) |
| Observable (M1) | 215 (3.6) | 215 (0.4) |
| Referable (M2) | 202 (3.4) | 202 (0.4) |
| Any Maculopathy | 417 (7.0) | 417 (0.7) |
| Laser Scars | ||
| No Laser Scars | 5957 (99.5) | 56742 (99.9) |
| Pan retinal laser | 23 (0.4) | 23 (0) |
| Macular laser | 1 (0.0) | 1 (0) |
| Pan retinal and macular laser | 5 (0.1) | 5 (0) |
| Any Retinopathy and /or Maculopathy | 1010 (16.9) | 1010 (1.8) |
| Sight Threatening DR (R4 or M2) | 214 (3.6) | 214 (0.4) |
| Diabetics (n=6717) | Non diabetics/ unknown status (n=50,815) | Total Examined (n=57532) |
|
|---|---|---|---|
| Blindness | 144 (2.1%) | 1035 (2.0) | 1179 (2.0) |
| Visual impairment | 923 (13.7%) | 7128 (14.0) | 8051 (13.9) |